1	M-CSF-Induces	_	NN	_	_	4	NMOD	_	_
2	PKCalpha	_	NN	_	_	4	NMOD	_	_
3	Kinase	_	NN	_	_	4	NMOD	_	_
4	Activity	_	NN	_	_	0	ROOT	_	_
		
1	Since	_	IN	_	_	24	VMOD	_	_
2	our	_	PRP$	_	_	3	NMOD	_	_
3	data	_	NNS	_	_	4	VMOD	_	_
4	suggested	_	VBD	_	_	1	SUB	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	conventional	_	JJ	_	_	7	NMOD	_	_
7	PKCs	_	NNS	_	_	8	VMOD	_	_
8	were	_	VBD	_	_	5	SUB	_	_
9	involved	_	VBN	_	_	8	VC	_	_
10	in	_	IN	_	_	9	VMOD	_	_
11	activating	_	VBG	_	_	10	PMOD	_	_
12	NF-kappaB	_	NN	_	_	11	VMOD	_	_
13	in	_	IN	_	_	11	VMOD	_	_
14	response	_	NN	_	_	13	PMOD	_	_
15	to	_	TO	_	_	14	NMOD	_	_
16	M-CSF	_	NN	_	_	15	PMOD	_	_
17	in	_	IN	_	_	14	NMOD	_	_
18	primary	_	JJ	_	_	20	NMOD	_	_
19	human	_	JJ	_	_	20	NMOD	_	_
20	macrophages	_	NNS	_	_	17	PMOD	_	_
21	,	_	,	_	_	24	P	_	_
22	we	_	PRP	_	_	24	VMOD	_	_
23	next	_	RB	_	_	24	VMOD	_	_
24	investigated	_	VBD	_	_	0	ROOT	_	_
25	whether	_	IN	_	_	24	VMOD	_	_
26	the	_	DT	_	_	30	NMOD	_	_
27	conventional	_	JJ	_	_	30	NMOD	_	_
28	PKC	_	NN	_	_	30	NMOD	_	_
29	,	_	,	_	_	30	P	_	_
30	PKCalpha	_	NN	_	_	31	VMOD	_	_
31	was	_	VBD	_	_	25	SUB	_	_
32	a	_	DT	_	_	34	NMOD	_	_
33	downstream	_	JJ	_	_	34	NMOD	_	_
34	target	_	NN	_	_	31	VMOD	_	_
35	of	_	IN	_	_	34	NMOD	_	_
36	M-CSF	_	NN	_	_	35	PMOD	_	_
37	in	_	IN	_	_	34	NMOD	_	_
38	human	_	JJ	_	_	39	NMOD	_	_
39	MDMs	_	NNS	_	_	37	PMOD	_	_
40	.	_	.	_	_	24	P	_	_
		
1	PKCalpha	_	NN	_	_	2	VMOD	_	_
2	was	_	VBD	_	_	0	ROOT	_	_
3	immunoprecipitated	_	VBN	_	_	2	VC	_	_
4	from	_	IN	_	_	3	VMOD	_	_
5	human	_	JJ	_	_	6	NMOD	_	_
6	MDMs	_	NNS	_	_	4	PMOD	_	_
7	at	_	IN	_	_	6	NMOD	_	_
8	the	_	DT	_	_	11	NMOD	_	_
9	indicated	_	VBN	_	_	11	NMOD	_	_
10	time	_	NN	_	_	11	NMOD	_	_
11	points	_	NNS	_	_	7	PMOD	_	_
12	(	_	(	_	_	13	P	_	_
13	Figure	_	NN	_	_	11	PRN	_	_
14	4	_	CD	_	_	13	NMOD	_	_
15	)	_	)	_	_	13	P	_	_
16	,	_	,	_	_	2	P	_	_
17	and	_	CC	_	_	2	COORD	_	_
18	then	_	RB	_	_	22	NMOD	_	_
19	a	_	DT	_	_	22	NMOD	_	_
20	PKC	_	NN	_	_	22	NMOD	_	_
21	kinase	_	NN	_	_	22	NMOD	_	_
22	assay	_	NN	_	_	23	VMOD	_	_
23	was	_	VBD	_	_	17	CONJ	_	_
24	performed	_	VBN	_	_	23	VC	_	_
25	using	_	VBG	_	_	24	VMOD	_	_
26	a	_	DT	_	_	28	NMOD	_	_
27	fluorescein-tagged	_	JJ	_	_	28	NMOD	_	_
28	peptide	_	NN	_	_	25	VMOD	_	_
29	as	_	IN	_	_	25	VMOD	_	_
30	a	_	DT	_	_	31	NMOD	_	_
31	substrate	_	NN	_	_	29	PMOD	_	_
32	.	_	.	_	_	2	P	_	_
		
1	As	_	IN	_	_	14	VMOD	_	_
2	shown	_	VBN	_	_	1	SUB	_	_
3	in	_	IN	_	_	2	VMOD	_	_
4	Figure	_	NN	_	_	3	PMOD	_	_
5	4	_	CD	_	_	4	NMOD	_	_
6	(	_	(	_	_	8	P	_	_
7	upper	_	JJ	_	_	8	NMOD	_	_
8	panel	_	NN	_	_	2	PRN	_	_
9	)	_	)	_	_	8	P	_	_
10	,	_	,	_	_	14	P	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	peptide	_	NN	_	_	13	NMOD	_	_
13	substrate	_	NN	_	_	14	VMOD	_	_
14	was	_	VBD	_	_	0	ROOT	_	_
15	maximally	_	RB	_	_	14	VMOD	_	_
16	phosphorylated	_	VBN	_	_	14	VC	_	_
17	within	_	IN	_	_	16	VMOD	_	_
18	10	_	CD	_	_	19	NMOD	_	_
19	minutes	_	NNS	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	stimulation	_	NN	_	_	20	PMOD	_	_
22	(	_	(	_	_	23	P	_	_
23	1.8-fold	_	NN	_	_	21	PRN	_	_
24	over	_	IN	_	_	23	NMOD	_	_
25	resting	_	VBG	_	_	26	NMOD	_	_
26	cells	_	NNS	_	_	24	PMOD	_	_
27	,	_	,	_	_	23	P	_	_
28	lower	_	JJR	_	_	29	NMOD	_	_
29	panel	_	NN	_	_	23	APPO	_	_
30	)	_	)	_	_	23	P	_	_
31	,	_	,	_	_	14	P	_	_
32	and	_	CC	_	_	14	COORD	_	_
33	then	_	RB	_	_	14	VMOD	_	_
34	returned	_	VBD	_	_	32	CONJ	_	_
35	to	_	TO	_	_	34	VMOD	_	_
36	basal	_	JJ	_	_	37	NMOD	_	_
37	levels	_	NNS	_	_	35	PMOD	_	_
38	by	_	IN	_	_	34	VMOD	_	_
39	15	_	CD	_	_	40	NMOD	_	_
40	minutes	_	NNS	_	_	38	PMOD	_	_
41	.	_	.	_	_	14	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	effect	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	not	_	RB	_	_	3	VMOD	_	_
5	seen	_	VBN	_	_	3	VC	_	_
6	in	_	IN	_	_	5	VMOD	_	_
7	M-CSF-stimulated	_	JJ	_	_	8	NMOD	_	_
8	monocytes	_	NNS	_	_	6	PMOD	_	_
9	when	_	WRB	_	_	15	VMOD	_	_
10	isogenic	_	JJ	_	_	11	NMOD	_	_
11	antibodies	_	NNS	_	_	15	VMOD	_	_
12	(	_	(	_	_	13	P	_	_
13	IgG	_	NN	_	_	11	PRN	_	_
14	)	_	)	_	_	13	P	_	_
15	were	_	VBD	_	_	3	VMOD	_	_
16	used	_	VBN	_	_	15	VC	_	_
17	for	_	IN	_	_	16	VMOD	_	_
18	immunoprecipitation	_	NN	_	_	17	PMOD	_	_
19	.	_	.	_	_	3	P	_	_
		
1	Western	_	NN	_	_	2	NMOD	_	_
2	blots	_	NNS	_	_	11	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	identical	_	JJ	_	_	5	NMOD	_	_
5	samples	_	NNS	_	_	3	PMOD	_	_
6	using	_	VBG	_	_	5	APPO	_	_
7	an	_	DT	_	_	8	NMOD	_	_
8	antibody	_	NN	_	_	6	VMOD	_	_
9	recognizing	_	VBG	_	_	8	APPO	_	_
10	PKCalpha	_	NN	_	_	9	VMOD	_	_
11	demonstrated	_	VBD	_	_	0	ROOT	_	_
12	that	_	IN	_	_	11	VMOD	_	_
13	equal	_	JJ	_	_	14	NMOD	_	_
14	amounts	_	NNS	_	_	17	VMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	PKCalpha	_	NN	_	_	15	PMOD	_	_
17	were	_	VBD	_	_	12	SUB	_	_
18	assayed	_	VBN	_	_	17	VC	_	_
19	(	_	(	_	_	20	P	_	_
20	Figure	_	NN	_	_	18	PRN	_	_
21	4	_	CD	_	_	20	NMOD	_	_
22	,	_	,	_	_	20	P	_	_
23	middle	_	NN	_	_	24	NMOD	_	_
24	panel	_	NN	_	_	20	APPO	_	_
25	)	_	)	_	_	20	P	_	_
26	.	_	.	_	_	11	P	_	_
		
